Concorde Asset Management, LLC Twist Bioscience Corp Transaction History
Concorde Asset Management, LLC
- $183 Million
- Q1 2025
A detailed history of Concorde Asset Management, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Concorde Asset Management, LLC holds 7,822 shares of TWST stock, worth $281,513. This represents 0.17% of its overall portfolio holdings.
Number of Shares
7,822
Previous 9,416
16.93%
Holding current value
$281,513
Previous $437,000
29.75%
% of portfolio
0.17%
Previous 0.24%
Shares
7 transactions
Others Institutions Holding TWST
# of Institutions
276Shares Held
70.1MCall Options Held
73.4KPut Options Held
43.8K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.24MShares$225 Million2.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$211 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.85MShares$211 Million0.4% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$195 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.81MShares$137 Million0.46% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $2.03B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...